Ordesekimab (AMG 714, PRV-015) is a fully human IgG1kappa anti-IL-15 (Interleukin Related) monoclonal antibody. The binding of Ordesekimab to IL-15 inhibits the interaction of IL-15 with the IL-2Rbeta and common gamma chain of the IL-15 receptor complex, but not with the IL-15Ralpha chain. Ordesekimab has the potential for study of nonresponsive celiac disease (NRCD)[1].
Molecular Weight:
(145.12 kDa)
Purity:
99.08
CAS Number:
[879293-15-9]
Target:
Interleukin Related
Application Notes:
MCE Product type: Inhibitory Antibodies
* VAT and and shipping costs not included. Errors and price changes excepted